Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

University of Alberta

$105,000.00

Effects of metabolic stress on pancreatic islet death and dysfunction, and their role in islet transplantation failure.

EF 2011-12

Résumé
Type 1 Diabetes mellitus is a serious disorder that results from the destruction of the insulin secreting cells of the body. The current treatment for this disease consists of the administration of insulin injections. Insulin injections, however, cannot accurately control blood glucose levels in all patients, and may still result in the development of high blood glucose-induced complications. The results of current treatment, therefore, are both painful and costly. In recent years, transplantation of the tissues that contain insulin-secreting cells, known as islet transplantation, has emerged as a long-term treatment for type 1 diabetes. Islet transplantation is able to provide insulin-independence to most recipients, and more importantly, islet transplantation has been shown to improve blood glucose levels when compared to conventional therapies. Despite these advancements, less than 10% of islet transplant recipients remain insulin independent after 5 years, indicating a failure of the transplant. This failure of islet transplants was traditionally attributed to immune-mediated destruction of the transplant, yet the ability of the transplants to fail in the absence of an immune-mediated has been demonstrated. These findings have lead to the suggestion that other factors may be responsible for the failure of the islet transplants. Recently, high blood sugars and fats have been shown to induce islet death and reduce insulin secretion. These factors can increase inflammation, and may be able to induce immune-mediated destruction of the transplant. We plan to determine whether high blood sugars and fats, known as metabolic stress, are required for, or complicit in, the long-term loss of islet transplants. In particular, we will examine which part of the islets are affected by metabolic stress, and identify potential drug targets which could be used pre-, post-, or co-transplantation to delay, or possibly prevent, future islet transplant failure.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
257448
Name
Hajmrle Catherine
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Effects of metabolic stress on pancreatic islet death and dysfunction, and their role in islet transplantation failure.
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Beta-Cell Death; Cell Imaging; Cell Signaling; Diabetes; Electrophysiology; Il-1beta; Islet Transplantation; Metabolism; Molecular Biology
Abstract
Type 1 Diabetes mellitus is a serious disorder that results from the destruction of the insulin secreting cells of the body. The current treatment for this disease consists of the administration of insulin injections. Insulin injections, however, cannot accurately control blood glucose levels in all patients, and may still result in the development of high blood glucose-induced complications. The results of current treatment, therefore, are both painful and costly. In recent years, transplantation of the tissues that contain insulin-secreting cells, known as islet transplantation, has emerged as a long-term treatment for type 1 diabetes. Islet transplantation is able to provide insulin-independence to most recipients, and more importantly, islet transplantation has been shown to improve blood glucose levels when compared to conventional therapies. Despite these advancements, less than 10% of islet transplant recipients remain insulin independent after 5 years, indicating a failure of the transplant. This failure of islet transplants was traditionally attributed to immune-mediated destruction of the transplant, yet the ability of the transplants to fail in the absence of an immune-mediated has been demonstrated. These findings have lead to the suggestion that other factors may be responsible for the failure of the islet transplants. Recently, high blood sugars and fats have been shown to induce islet death and reduce insulin secretion. These factors can increase inflammation, and may be able to induce immune-mediated destruction of the transplant. We plan to determine whether high blood sugars and fats, known as metabolic stress, are required for, or complicit in, the long-term loss of islet transplants. In particular, we will examine which part of the islets are affected by metabolic stress, and identify potential drug targets which could be used pre-, post-, or co-transplantation to delay, or possibly prevent, future islet transplant failure.
Competitiondate
201110
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Hajmrle, Catherine
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~